Merck KGaA
OTC:MKGAF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Merck KGaA
OTC:MKGAF
|
DE |
|
G
|
Grifols SA
MAD:GRF.P
|
ES |
|
S
|
Sumitomo Corp
DUS:SUMA
|
JP |
|
Innate Pharma SA
F:IDDA
|
FR |
Wall St Price Targets
MKGAF Price Targets Summary
Merck KGaA
According to Wall Street analysts, the average 1-year price target for MKGAF is 165.45 USD with a low forecast of 132.34 USD and a high forecast of 212.31 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MKGAF's stock price target?
Price Target
165.45
USD
According to Wall Street analysts, the average 1-year price target for MKGAF is 165.45 USD with a low forecast of 132.34 USD and a high forecast of 212.31 USD.
What is the Revenue forecast for Merck KGaA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Merck KGaA?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Merck KGaA?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 8 years is 6%.
What is the Pre-Tax Income forecast for Merck KGaA?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 14%.
What is the Net Income forecast for Merck KGaA?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 8 years is 12%.
